Abdominal myomectomy.........................................................23
Adnexal lesion...........................................................................165
Adnexal preservation................................................................165
Androgenization........................................................................255
Anovulation................................................................................255
Anti-mullerian hormone.............................................................65
Anxiety........................................................................................142
Assessment................................................................................170
Assisted reproductive technology.............................................55
Attitudes.....................................................................................138
Bem Sex Role Inventory...........................................................138
Beta-human chorionic gonadotrophin.....................................97
Biopsy.........................................................................................117
Bipolar cord coagulation............................................................79
Bladder pain..............................................................................117
Bleeding.....................................................................................123
Body mass index.........................................................................89
Borderline ovarian tumors.......................................................224
C1q/tumor necrosis factor-related protein-5 ..............................89
Cadaveric...................................................................................243
Carcinosarcoma........................................................................154
Central nervous system............................................................170
Cervical cerclage......................................................................272
Climacteric.................................................................................178
Clinical characteristics.............................................................133
Cognitive behavioral therapy...................................................178
Congenital abnormalities.........................................................170
Cortisol.......................................................................................218
Cystoscopy.................................................................................117
Cytoreduction..............................................................................62
Cytoreductive surgery.................................................................31
Darbepoietin................................................................................41
Deeply infiltrating endometriosis............................................133
Dental health.............................................................................264
Developing world......................................................................106
Dissection...................................................................................243
Donor programme....................................................................236
Donors........................................................................................236
Double-balloon catheter..........................................................231
Education...................................................................................243
Endometriosis......................................................................41, 133
Environmental...........................................................................255
Enzian classification.................................................................133
Erythropoietin..............................................................................41
Ethics..........................................................................................236
Female students........................................................................138
Fertility preservation.................................................................196
Fibroid............................................................................15, 55, 211
First trimester...............................................................................37
First trimester screening.............................................................97
Free-androgen index..................................................................89
Gender-role orientation............................................................138
Genetic factors..........................................................................255
Gestational hypertension.........................................................106
Granulosa cell ovarian tumor..................................................247
Gynecologic...............................................................................123
Hemostasis..................................................................................23
Hemostatic tourniquet...............................................................23
HIPEC.........................................................................................213
Huge myoma.............................................................................211
Hydrodistension........................................................................117
Hyperandrogenism...................................................................255
Hypogastric................................................................................123
Hysterectomy.......................................................................15, 165
In vitro fertilization................................................................55, 97
Infertility.....................................................................................255
Infertility treatment.....................................................................84
Insulin resistance........................................................................89
Interstitial laser............................................................................79
Interval.......................................................................................272
Intracytoplasmic sperm injection.............................................97
Intrauterine insemination............................................................1
Iodine deficiency.........................................................................37
Intrauterine death.....................................................................147
Labor induction.........................................................................231
Laparoscopy..............................................................................272
Leiomyoma..................................................................................55
Leiomyosarcoma......................................................................154
Leptin.........................................................................................218
Liver..............................................................................................62
Malignant degeneration.............................................................84
Management..............................................................................213
Mature cystic teratoma...............................................................84
Menopause................................................................................178
Menstruation..............................................................................138
Meta-learning...............................................................................70
MIRCERA......................................................................................41
Minimally invasive.........................................................................8
Misoprostol..................................................................................23
Monochorionic............................................................................79
mTOR.........................................................................................247
national program.......................................................................196
Neoadjuvant chemotherapy......................................................31
Neonatal death............................................................................70
Neurosurgical procedure.........................................................170
Nuchal translucency...................................................................97
Occupational.............................................................................255
Oncofertility...............................................................................196
Oocyte donation........................................................................236
Oocyte-embryo freezing..........................................................196
Oral care....................................................................................264
Ovarian cancer..............................................................47, 62, 247
Ovarian capacity.........................................................................65
Ovarian carcinoma...................................................................213
Pelvic..........................................................................................123
Pelvis...........................................................................................243
Perinatal outcomes...................................................................147
Perioperative outcomes...............................................................8
Phenotyping...............................................................................117
Polycystic ovary syndrome.......................................................255
Polycystic ovary syndrome.........................................................89
Pont hepatique............................................................................62
Postoperative.............................................................................142
Postpartum.................................................................................123
Pregnancy......................................................................37, 97, 264
Pregnancy complications.........................................................218
Pregnancy outcomes................................................................147
Pregnancy rate...............................................................................1
Pregnancy-associated plasma protein-A..................................97
Prenatal diagnosis.....................................................................170
Preoperative...............................................................................142
Preterm birth...............................................................................70
Primary prevention.....................................................................47
Primary surgery...........................................................................31
Prognosis............................................................................154, 213
Radiofrequency ablation............................................................79
Rapamycin.................................................................................247
Rat.................................................................................................65
Rational drug treatment.............................................................65
Re-operation..............................................................................165
Receptor activator.......................................................................41
ReCoDe intrauterine fetal demise...........................................106
Recurrence................................................................................213
Relapse.......................................................................................213
Residual.....................................................................................213
Risk factors..................................................................................15
Risk factors of preterm birth......................................................70
Robotic myomectomy..............................................................211
Salpingectomy.............................................................................47
Salpingo-oophorectomy.............................................................47
Sarcoma...............................................................................15, 154
Selective fetal reduction.............................................................79
Single twin demise...................................................................147
Sperm parameters........................................................................1
St. John’s wort.............................................................................65
Stacked ensemble......................................................................70
Stacked generalization...............................................................70
Stage...........................................................................................224
Stillbirth......................................................................................106
Stress..........................................................................................218
Surgical findings........................................................................133
Survival.................................................................31, 154, 213, 224
Symptoms..................................................................................178
Technique..................................................................................272
Total abdominal hysterectomy................................................142
Total laparoscopic hysterectomy............................................142
Transobturator...........................................................................243
Treatment modalities...............................................................196
Twin pregnancy.........................................................................147
Umbilical ligament......................................................................62
Unfavorable cervix....................................................................231
Uterine..........................................................................................15
Uterine leiomyoma.....................................................................23
Uteroplacental insufficiency....................................................106
Vaginal hysterectomy....................................................................8
